Update under Regulation 30 read with Para A Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
MEDPLUS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
MedPlus Health Services has informed exchanges that its subsidiary, Optival Health Solutions Private Limited, received a one-day suspension order for the drug license of its store located at Koratagere, Tumkur, Karnataka. The order was issued by the Assistant Director, Drugs Control Administration, Tumkur Circle, under Rule 65 of the Drugs and Cosmetics Act, 1940, and was received on February 19, 2026. The company has quantified the potential revenue loss from this single-day suspension at approximately Rs 0.33 lakhs (around Rs 33,000). This is a routine regulatory compliance update filed under SEBI Listing Regulations.
The impact is negligible for shareholders — a one-day suspension of a single store results in a revenue loss of only about Rs 33,000, which is immaterial relative to MedPlus's overall business. This is unlikely to have any meaningful effect on the stock price or operations.